Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
UBS analyst Kevin Caliendo maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and lowers the price target from $9 t...
Barclays analyst Stephanie Davis maintains LifeStance Health Gr (NASDAQ:LFST) with a Underweight and lowers the price target...
2024 Guidance LifeStance is providing the following outlook for 2024: The Company is raising full year revenue to $1.2 bill...
2024 Guidance LifeStance is providing the following outlook for 2024: The Company is raising full year revenue to $1.2 bill...
LifeStance Health Gr (NASDAQ:LFST) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of ...
Lifeist Wellness Inc. (TSXV: LFST) (FRANKFURT: M5B0) (OTCMKTS: LFSWF), a health-tech company reported on Tuesday its financial ...
Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors.Sandy Li, w...
Simply Solventless Concentrates Ltd. (TSXV: HASH) is acquiring Lifeist Wellness Inc.'s (TSXV: LFST) (FRANKFURT: M5B) (OTCMK...
